Trial · NCT01795833
Diabetes Prevention Using SMS Technology
NCT01795833, Not applicable, Completed, Imperial College London; results first posted 2019-11-12
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. Diabetes Prevention Using SMS Technology. Trials, record NCT01795833. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT01795833
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Diabetes Prevention Using SMS Technology
- NCT number
- NCT01795833
- Status
- Completed
- Phases
- Not applicable
- Enrollment
- 2,062 participants, actual
- Lead sponsor
- Imperial College London
- Conditions
- Prediabetes
- Interventions
- Short text messages
- First posted
- 2013-02-21
- Last updated
- 2020-10-30
- Results first posted
- 2019-11-12
Source ClinicalTrials.gov
Registered outcomes7
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Number of Participants With Progression to Type 2 Diabetes | 24 months | The primary outcome will be progression to type 2 diabetes as measured by HbA1c at baseline, 6 months, 12 months and 24 months or by any validated criteria in any other care setting. the World health Organization (WHO) / International Diabetes Federation (IDF) criteria for diagnosis of diabetes will be used throughout. |
| Secondary | Body Weight | Baseline and 24 months | |
| Secondary | Blood Pressure | Baseline and 24 months | |
| Secondary | HDL Cholesterol | Baseline and 24 months | |
| Secondary | LDL Cholesterol | Baseline and 24 months | |
| Secondary | Triglycerides | Baseline and 24 months | |
| Secondary | Total Physical Activity | Baseline and 24 months | counts/minute, actigraph |
Source ClinicalTrials.gov
Outcomes7
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
| Type | Outcome | Time frame | Population | Units | Measured as |
|---|---|---|---|---|---|
| PRIMARY | Number of Participants With Progression to Type 2 Diabetes | 24 months | Participants | COUNT_OF_PARTICIPANTS | |
| SECONDARY | Body Weight | Baseline and 24 months | kg | MEAN | |
| SECONDARY | Blood Pressure | Baseline and 24 months | mmHg | MEAN | |
| SECONDARY | HDL Cholesterol | Baseline and 24 months | mmol/L | MEAN | |
| SECONDARY | LDL Cholesterol | Baseline and 24 months | mmol/L | MEAN | |
| SECONDARY | Triglycerides | Baseline and 24 months | mmol/L | MEAN | |
| SECONDARY | Total Physical Activity | Baseline and 24 months | counts/minute | MEAN |
Source ClinicalTrials.gov
Results by group30
Each measurement the trial posted, group by group, in the words and numbers it posted.
| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Number of Participants With Progression to Type 2 Diabetes | Text Messages | 216 | Participants | ||
| Number of Participants With Progression to Type 2 Diabetes | Control | 234 | Participants | ||
| Body Weight | Text Messages | Baseline | 79 | Standard Deviation 15.4 | kg |
| Body Weight | Control | Baseline | 79.7 | Standard Deviation 15.6 | kg |
| Body Weight | Text Messages | 24 months | 77.4 | Standard Deviation 14.7 | kg |
| Body Weight | Control | 24 months | 78.1 | Standard Deviation 14.9 | kg |
| Blood Pressure | Text Messages | Baseline Systolic | 128.8 | Standard Deviation 17 | mmHg |
| Blood Pressure | Control | Baseline Systolic | 129.3 | Standard Deviation 16.8 | mmHg |
| Blood Pressure | Text Messages | Baseline Diastolic | 81 | Standard Deviation 10.6 | mmHg |
| Blood Pressure | Control | Baseline Diastolic | 81.5 | Standard Deviation 10.6 | mmHg |
1 to 10 of 30Source ClinicalTrials.gov
See all 30 results by groupParticipant flow6
How many started, completed or left each group, period by period.
| Period | Milestone | Group | Participants | Units counted |
|---|---|---|---|---|
| Overall Study | STARTED | Text Messages | 1,031 | |
| Overall Study | STARTED | Control | 1,031 | |
| Overall Study | COMPLETED | Text Messages | 881 | |
| Overall Study | COMPLETED | Control | 882 | |
| Overall Study | NOT COMPLETED | Text Messages | 150 | |
| Overall Study | NOT COMPLETED | Control | 149 |
Source ClinicalTrials.gov
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals6
The totals the trial posted for each group.
| Total | Group | Affected | At risk |
|---|---|---|---|
| Total, all-cause mortality | Text Messages | 2 | 1,031 |
| Total, all-cause mortality | Control | 1 | 1,031 |
| Total, other adverse events | Text Messages | 0 | 1,031 |
| Total, other adverse events | Control | 0 | 1,031 |
| Total, serious adverse events | Text Messages | 0 | 1,031 |
| Total, serious adverse events | Control | 0 | 1,031 |
Source ClinicalTrials.gov
Papers2
The papers the trial lists on ClinicalTrials.gov.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons3
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
| Comparison | Source |
|---|---|
| Text Messages vs Control: Number of Participants With Progression to Type 2 Diabetes | Trial comparisons |
| Text Messages vs Control: deaths from any cause | Trial comparisons |
| Text Messages vs Control: serious adverse events | Trial comparisons |
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT01795833
GET https://conductscience.org/api/trials/v1/NCT01795833/results?page=2